35 results on '"Chen, Zhui"'
Search Results
2. TCGA RNA-seq and Tumor-Infiltrating Lymphocyte Imaging Data Reveal Cold Tumor Signatures of Invasive Ductal Carcinomas and Estrogen Receptor-Positive Human Breast Tumors
3. Abstract LB329: A potent and selective small molecule inhibitor of CSF-1R ABSK021 demonstrates strong efficacy in preclinical models of osteosarcoma
4. Abstract LB328: Discovery & characterization of a next-generation FGFR4 inhibitor overcoming resistant mutations
5. Abstract LB316: A next-generation KRASG12C inhibitor ABSK071 demonstrated broad synergy with other therapeutic agents in KRASG12C mutated cancer models
6. Abstract LB317: Discovery and characterization of a next-generation FGFR inhibitor overcoming FGFR resistant mutations
7. Abstract LB327: Discovery and characterization of ABSK112, a next-generation and potential best-in-class EGFR Exon20 mutant inhibitor with superior selectivity and brain penetration ability
8. 905 Broad anti-tumor activity of a potent and selective small molecule antagonist of PD-L1 ABSK043 in combination with other agents in preclinical models
9. 1441 A potent and selective small molecule antagonist of CD73 ABSK051 reverses immunosuppression through reduction of adenosine production
10. 985 Inhibition of fibroblast growth factor receptor 4 (FGFR4) signaling activates tumor interferon (IFN) signaling in hepatocellular carcinoma (HCC)
11. Abstract LB513: In vivo efficacy screen of a CSF-1R inhibitor ABSK021 in mouse syngeneic tumor models reveals immune features that may predict its therapeutic response
12. Abstract LB530: A potent and selective small molecule antagonist of PD-L1 ABSK043 demonstrates significant anti-tumor efficacy in combination with other agents in preclinical models
13. Abstract LB525: Discovery and characterization of ABSK111, a selective, CNS-penetrable, and broad-spectrum EGFR inhibitor targeting exon20 insertion, atypical and extracellular mutations
14. Immobilized Magnetic Beads-Based Multi-Target Affinity Selection Coupled with HPLC-MS for Screening Active Compounds from Traditional Chinese Medicine and Natural Products
15. Immobilized magnetic beads based multi-target affinity selection coupled with high performance liquid chromatography–mass spectrometry for screening anti-diabetic compounds from a Chinese medicine “Tang-Zhi-Qing”
16. Activation of MEKK1 by Rho GTPases
17. High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors
18. Abstract LB-A17: Discovery and characterization of a novel small molecule antagonist of PD-L1
19. Abstract LB-A17: Discovery and characterization of a novel small molecule antagonist of PD-L1
20. The C-terminal Polylysine Region and Methylation of K-Ras Are Critical for the Interaction between K-Ras and Microtubules
21. Abstract LB-288: A highly selective small molecule CSF-1R inhibitor demonstrates strong immunomodulatory activity in syngeneic models
22. Abstract LB-272: Discovery and characterization of a novel FGFR4 Inhibitor for the treatment of hepatocellular carcinoma
23. Abstract LB-288: A highly selective small molecule CSF-1R inhibitor demonstrates strong immunomodulatory activity in syngeneic models
24. Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells
25. Histone Demethylase LSD1 Promotes Adipocyte Differentiation through Repressing Wnt Signaling
26. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
27. Rapid identification of anti-inflammatory compounds from Tongmai Yangxin Pills by liquid chromatography with high-resolution mass spectrometry and chemometric analysis
28. JAK2V617F Drives Mcl-1 Expression and Sensitizes Hematologic Cell Lines to Dual Inhibition of JAK2 and Bcl-xL
29. Corrigendum to “Immobilized magnetic beads based multi-target affinity selection coupled with high performance liquid chromatography–mass spectrometry for screening anti-diabetic compounds from a Chinese medicine “Tang-Zhi-Qing”” [J. Pharm. Biomed. Anal. 78–79 (2013) 190–201]
30. Characterization ofα-Amylase Binding Agents from Hawthorn Leaf Using Ultrafiltration and Liquid Chromatography Tandem Mass Spectrometry
31. JAK2V617F Drives Mcl-1 Expression and Sensitizes Hematologic Cell Lines to Dual Inhibition of JAK2 and Bcl-xL.
32. Experimental Research on Electronic Expansion Valve Refrigerant Flow Coefficient.
33. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53.
34. NUMERICAL K-ELECTRON FUNCTIONS FOR DETERMINING THE PROBABILITIES OF ALLOWED AND FORBIDDEN K CAPTURE
35. Immobilized magnetic beads-based multi-target affinity selection coupled with HPLC-MS for screening active compounds from traditional Chinese medicine and natural products.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.